Univest
Univest
  • Markets
  • SIS Share Price Gains 2.14% After Q1 FY27 Results

    • August 6, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    SIS Share Price Gains 2.14% After Q1 FY27 Results

    SIS share price gains 2.14% to Rs 439.75 after Q1 FY27 results. Security and Facility Management Services sector. Key analysis for investors tracking the stock.

    read more
  • ICICI Bank Share: Pros and Cons Every Investor Must Know in 2026

    • August 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    ICICI Bank Share: Pros and Cons Every Investor Must Know in 2026

    Know the pros and cons of ICICI Bank share. Complete 2026 analysis of India’s fastest-growing large private bank covering ROA leadership, retail strategy, digital edge, and investment risks.

    read more
  • IRCTC vs Easy Trip Planners: Which Stock Should You Track

    • August 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    IRCTC vs Easy Trip Planners: Which Stock Should You Track

    IRCTC vs Easy Trip Planners compared on ticketing volumes, revenue model, ROE and valuation. Full data-backed breakdown for online travel booking investors.

    read more
  • Pearl Global Industries Share Price Gains 0.74% After Q1 FY27 Results

    • August 6, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Pearl Global Industries Share Price Gains 0.74% After Q1 FY27 Results

    Pearl Global Industries share price gains 0.74% to Rs 2,120.00 after Q1 FY27 results. Apparel Manufacturing and Garments sector. Key analysis for investors tracking the s

    read more
  • Savita Oil Technologies Share Price Gains 18.55% After Q1 FY27 Results

    • August 6, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Savita Oil Technologies Share Price Gains 18.55% After Q1 FY27 Results

    Savita Oil Technologies share price gains 18.55% to Rs 804.95 after Q1 FY27 results. Petroleum Products and Lubricants sector. Key analysis for investors tracking the sto

    read more
  • Shree Renuka Sugars Share Price Falls 1.66% After Q1 FY27 Results

    • August 6, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Shree Renuka Sugars Share Price Falls 1.66% After Q1 FY27 Results

    Shree Renuka Sugars share price falls 1.66% to Rs 21.96 after Q1 FY27 results. Sugar and Ethanol sector. Key analysis for investors tracking the stock.

    read more
  • RattanIndia Enterprises Share Price Falls 1.72% After Q1 FY27 Results

    • August 6, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    RattanIndia Enterprises Share Price Falls 1.72% After Q1 FY27 Results

    RattanIndia Enterprises share price falls 1.72% to Rs 31.99 after Q1 FY27 results. Technology and Financial Services sector. Key analysis for investors tracking the stock

    read more
  • Pace Digitek Share Price Falls 6.79% After Q1 FY27 Results

    • August 6, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Pace Digitek Share Price Falls 6.79% After Q1 FY27 Results

    Pace Digitek share price falls 6.79% to Rs 187.20 after Q1 FY27 results. Technology Distribution and Services sector. Key analysis for investors tracking the stock.

    read more
  • Datamatics Global Services Share Price Falls 2.14% After Q1 FY27 Results

    • August 6, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Datamatics Global Services Share Price Falls 2.14% After Q1 FY27 Results

    Datamatics Global Services share price falls 2.14% to Rs 858.35 after Q1 FY27 results. IT and Business Process Automation sector. Key analysis for investors tracking the

    read more
  • Cipla Share: Pros and Cons Every Investor Must Know in 2026

    • August 6, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Cipla Share: Pros and Cons Every Investor Must Know in 2026

    Cipla share pros and cons: respiratory pharma leader and South Africa giant analysed for 2026. Covers inhaler expertise, access pharma legacy, US pipeline gaps, and PE valuation.

    read more
  • 1
  • …
  • 906
  • 907
  • 908
  • 909
  • 910
  • …
  • 2,708